Where is the FY2027 ICD-10-CM Neoplasm Table?

It is part of the official FY2027 U.S. ICD-10-CM Alphabetic Index. Start at the CDC/NCHS FY2027 release page and follow its Table and Index files, or use the official FY2027 source folder to identify the ICD-10-CM Table and Index archive. The FY2027 Official Guidelines, section I.A.1, identify the Neoplasm Table as one of the Alphabetic Index's parts. It is neither a separate classification nor a substitute for the Tabular List.

This is a guide to finding and labeling a source. It does not interpret a tumor record, decide behavior or site, or select a diagnosis code. Those decisions require the full documentation and qualified human review. If your saved bookmark has no fiscal-year label, open the versioned FY2027 Neoplasm Table reference and compare its release label with the official CDC/NCHS files before relying on it.

The U.S. FY2027 ICD-10-CM release applies to healthcare services from October 1, 2026 through September 30, 2027, as stated on the CDC/NCHS release page. Its source folder groups the Table and Index archive with the FY2027 Tabular List, addenda and other diagnosis files. Note the exact file name and the date you retrieved it; a later official update would need to be checked separately. The CMS ICD-10 files page also separates 2027 ICD-10-CM diagnosis files from ICD-10-PCS procedure files.

The FY2027 guidelines describe four parts of the Alphabetic Index: the Index of Diseases and Injury, Index of External Causes of Injury, Table of Neoplasms, and Table of Drugs and Chemicals. The Table of Neoplasms is thus a named lookup component within the diagnosis Index. The CDC/NCHS ICD-10-CM browser information describes release selection and navigation between the Index and Tabular List, including the Table of Neoplasms.

A table reference can help a reader find a possible path in the released classification. It cannot show every instruction attached to a full Tabular entry. The CMS guideline's general Index-to-Tabular rule, section I.B.1, says a code located in the Alphabetic Index must still be verified in the Tabular List. Section I.C.2 gives additional neoplasm-specific direction. Read those sections in the official PDF rather than treating a table cell, snippet or third-party search result as a complete rule. The Index-and-Tabular primer explains this relationship across ICD-10-CM.

1. Label the classification and year. Record “U.S. FY2027 ICD-10-CM” and the October 1, 2026–September 30, 2027 period from CDC/NCHS.
2. Open the official Index source. Locate the Neoplasm Table in the FY2027 Table and Index archive or in an official year-selected browser view. Keep the file or browser release visible.
3. Keep the reference and its context together. A table cell is an Index reference. For any real coding question, the complete Tabular entry and applicable official instructions must be reviewed. The FY2027 guidelines provide the general verification rule and the neoplasm chapter guidance.
4. Escalate interpretation. If a question turns on documented histology, behavior, site, sequencing or a patient's record, seek qualified human coding review. This source trail does not resolve those details.

Diagram-ready takeaway: FY2027 release label → official Alphabetic Index / Neoplasm Table → complete Tabular entry → qualified case review. Save that chain beside a screenshot or shared link so the next person can see which release and source were used. Our FY2027 source library and versioned table route provide convenient navigation back to the official source family.

The table above is about evidence provenance, not a shortcut for cancer coding. The parent-note guide explains why a displayed leaf entry may omit instructions inherited from higher Tabular levels. The addenda checklist explains how to distinguish a change record from the full released entry.

When moving from a browser to a saved reference, retain the year, classification and source link. ICD Code Hub's Android, iPhone and Mac apps offer available versioned reference routes; the shared store destinations below link to the current listings. For the definitive file and effective period, return to CDC/NCHS. For the published verification and neoplasm guidance, read the CMS FY2027 guidelines.

This article is educational source navigation. It does not provide a patient-specific code, clinical interpretation or payment conclusion.